99% Savings - Buy Just @1 Rs X
Revlamer, a prescription drug, is manufactured in various forms such as Tablet. Increased Phosphate Levels in the Blood are some of its major therapeutic uses. Secondary and off-label uses of Revlamer have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Revlamer. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Revlamer side effects, there are can be others also. These have been listed below. Such side effects of Revlamer normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Revlamer is Unknown for pregnant women and Safe for women who are breastfeeding. In addition, Revlamer's effects on the liver, heart and kidney are discussed below in the Revlamer related warnings section.
Revlamer is not recommended if you suffer from certain medical conditions as it can have adverse effects. Intestinal Obstruction are examples of such conditions. Some other conditions that can be affected by Revlamer are listed in the contraindications section below.
Drug reaction of Revlamer with other medicines has been reported. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Revlamer is safe while driving, and is is addictive in nature.
Revlamer is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Is the use of Revlamer safe for pregnant women?
No research has been done to ascertain the safety of Revlamer in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Revlamer safe during breastfeeding?
Breastfeeding women can safely use Revlamer.
What is the effect of Revlamer on the Kidneys?
Revlamer rarely harms the kidneys.
What is the effect of Revlamer on the Liver?
Information about safety of Revlamer for the liver is not available since scientific research on this is yet to be done.
What is the effect of Revlamer on the Heart?
In the absence of any scientific study on the side effects of Revlamer on the heart, information on safety of Revlamer for the heart is unavailable.
Revlamer should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Revlamer unless your doctor advises you to do so -
Is this Revlamer habit forming or addictive?
Revlamer is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Revlamer does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, Revlamer is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Revlamer is unable to treat or cure mental disorders.
Interaction between Food and Revlamer
Due to a lack of research, nothing can be said about the consequences of taking Revlamer together with food.
Interaction between Alcohol and Revlamer
No research has been done on this till date. Therefore, it is not known what the effect of taking Revlamer with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renvela (sevelamer carbonate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1134-1135